FDA Warns of Ketoacidosis with Certain Diabetes Drugs

An article on the American Academy of Family Physicians’ website discussed the FDA’s recent move to add warnings to the labels of diabetes drugs like Invokana to notify users about the potential risk of ketoacidosis. The article also cautioned physicians whose patients are on these diabetes drugs to watch for signs of ketoacidosis and to make patients aware of the symptoms so they can seek medical attention should symptoms appear. The FDA also noted that while a number of adverse events have been reported with this particular type of diabetes drug, the actual number of adverse events is most likely higher since the reporting is done on a voluntary basis only.

Read more